Supriya Lifescience Ltd. Conference Calls and Earnings Call Transcripts

Supriya Lifescience Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter
All Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Supriya Lifescience Ltd.
13 Jun 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on June 13, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
pdf
logo
Supriya Lifescience Ltd.
27 May 2022
732.50
-0.22%
pdf
logo
Supriya Lifescience Ltd.
23 May 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Audio Recording Of Earnings Call
BSE India
In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., May 23, 2022) regarding discussion on operational and financial performance for the Fourth Quarter and Financial Year ended March 31, 2022 (Q4 and FY 2021-22) is available on the Company''s website. The recording can be accessed from the link given below: https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/ Kindly take the information on record.
pdf
logo
Supriya Lifescience Ltd.
23 May 2022
732.50
-0.22%
Earnings Call for Q4FY22 of Supriya Lifescience
Conference Call with Supriya Lifescience Manhttps://youtu.be/CvlNlXdt8Ksagement and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
video
 
logo
Supriya Lifescience Ltd.
16 Mar 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on March 16, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
pdf
logo
Supriya Lifescience Ltd.
14 Mar 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on March 14, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
pdf
logo
Supriya Lifescience Ltd.
07 Mar 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investors/analysts on March 7, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
pdf
logo
Supriya Lifescience Ltd.
04 Mar 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investor/analyst on March 4, 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
pdf
logo
Supriya Lifescience Ltd.
15 Feb 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that the Officials of Supriya Lifescience Limited ('Company') had interacted with institutional investor/analyst on 15th February 2022 via video conference. This is to further inform that the copy of the Investor Presentation which was referred during the meeting has been already uploaded on the website of the Company www.supriyalifescience.com and is also available on the Stock Exchanges for the public at large. No unpublished price sensitive information (UPSI) was discussed during the interactions. Request you to kindly take the same on record.
pdf
logo
Supriya Lifescience Ltd.
25 Jan 2022
732.50
-0.22%
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Friday, January 21, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31, 2021 (Q3 of FY 2021-22). This intimation is also being made available on the website of the Company at: https://supriyalifescience.com/investor-relation/ Kindly take the information on record.
pdf

No results found

Earnings Calls Podcast on